Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

56.21 -4.27 (-7.06%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,957,679
Open 60.84
Bid (Size) 56.27 (2)
Ask (Size) 56.90 (10)
Prev. Close 60.48
Today's Range 55.82 - 61.47
52wk Range 37.55 - 91.10
Shares Outstanding 78,935,098
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Gene Editing Stocks That Could Grow Your Wealth
Investors looking for gene editing stocks of cutting edge technology firms should consider these biotech stocks. 
Via InvestorPlace
3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition
Explore gene-editing stocks with potential to become multibaggers as the industry advances in treating genetic disorders. 
Via InvestorPlace

Performance

YTD
-14.91%
-14.91%
1 Month
-7.20%
-7.20%
3 Month
+0.09%
+0.09%
6 Month
-7.82%
-7.82%
1 Year
-3.29%
-3.29%

More News

Read More
Blue Chips, Small Caps Extending Their Breakout
Via Talk Markets
Topics Stocks
Exposures US Equities
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
Via The Motley Fool
1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid
Via The Motley Fool
Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates
Via Benzinga
Topics ETFs
3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices
Via MarketBeat
3 Profitable CRISPR Stocks Earning Analysts’ Praise
Via InvestorPlace
7 Growth Stocks to Invest $500 In and Cash Out $100K by 2030
Via InvestorPlace
The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024
Via InvestorPlace
The 3 Best Gene Editing Stocks to Buy in July 2024
Via InvestorPlace
3 Pharma Stocks Already Ushering in the Next Biotech Boom
Via InvestorPlace
3 Top-Rated Gene Editing Stocks Actually Making Money
Via InvestorPlace
Trading SMID Biotech Stocks In A Volatile Market
Via Talk Markets
You’ve Been Warned! 3 Gene Editing Stocks to Buy Now or Regret Forever.
Via InvestorPlace
Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich
Via InvestorPlace
You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.
Via InvestorPlace
Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued."
Via The Motley Fool
3 Biotech Stocks That Could Make Your Grandchildren Rich
Via InvestorPlace
Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich
Via InvestorPlace
3 Gene Editing Stocks That Could Make Your Grandchildren Rich
Via InvestorPlace
The Next Big Thing After AI? 3 Sleeper Stocks to Buy Before the Boom
Via InvestorPlace
7 ‘FIRE’ Stocks to Put You on the Path to Financial Freedom
Via InvestorPlace
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
Via The Motley Fool
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.